Современное состояние методов визуализации в выявлении рака предстательной железы

Современное состояние методов визуализации в выявлении рака предстательной железы

Автор: Сосновский Никита Валерьевич, Розенгауз Е.В., Школьник М.И., Нестеров Д.В.

Журнал: Вестник Национального медико-хирургического центра им. Н.И. Пирогова @vestnik-pirogov-center

Рубрика: Обзоры литературы

Статья в выпуске: 4 т.11, 2016 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140188619

IDR: 140188619

Список литературы Современное состояние методов визуализации в выявлении рака предстательной железы

  • Ахвердиева Г.И, Санай Э.Б, Панов В.О, Губский И.Л, Тюрин И.Е, Долгушин Б.И, Матвеев В.Б, Камолов Б.Ш. Мультипараметрическая МРТ в диагностике рака предстательной железы Российский электронный журнал радиологии. 2013(4). Available at:http://www.rejr.ru/volume/12/achverdieva.pdf (Дата обращения 15.03.2016).
  • Евтушенко Е.В, Минько Б.А, Холин А.В, Михайлова Е.А. Ультразвуковая ангиография в диагностике рака предстательной железы. Санкт-Петербург. Издательский дом СПбМАПО, 2004. -92 с.
  • Матвеев Б.П., Бухаркин Б.В., Матвеев В.Б. Рак предстательной железы. М.: Медицинское издание, 1999. -154 c.
  • Петров С.Б. Хирургия предстательной железы. -СПб.: Издательство Сергея Ходова, 2004. -270 с.
  • Ackerstaff E, Pflug B, Nelson J, et al: Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61:3599-3603, 2001.
  • Barentsz JO, Richenberg J, Clements R, et al. ESUR prostate MR guidelines 2012. Eur Radiol 2012; 22: 746-57.
  • Bjurlin M.A. et al. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing//J. Urol. 2013. Vol. 189, № 6. P. 2039-2046.
  • Bogers HA, Sedelaar JP, Beerlage HP, et al. Contrast-enhanced threedimensional power Doppler angiography of the human prostate: correlation with biopsy outcome. Urology 1999; 54: 97-104. Bolla M. et al. Guidelines on Prostate Cancer. 2015.
  • Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MRI.//J Comput Assist Tomogr 1991; 15: 621-628.
  • Buckley DL, Roberts C, Parker GJ, Logue JP, Hutchinson CE. Prostate cancer: evaluation of vascular characteristics with dynamic contrastenhanced T1-weighted MR imaging-initial experience.//Radiology 2004;233: 709-715.
  • Cher Heng Tan, Brian Paul Hobbs, Wei Wei, Vikas Kundra. Dynamic Contrast-Enhanced MRI for the Detection of Prostate Cancer: Meta-Analysis AJR 2015; 204: W439-W448.
  • Cher Heng Tan, Wei Wei, Valen Johnson, Vikas Kundra. Diffusion-Weighted MRI in the Detection of Prostate Cancer: Meta-Analysis. AJR 2012; 199: 822-829.
  • Claus FG, Hricak H, Hattery RR. Pretreatment evalution of prostate cancer: role of MR imaging and H MR spectroscopy.//RadioGraphics 2004; 24 (suppl 1): S167-S180.
  • Cornud F, Hamida K, Flam T, et al. Endorectal color doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings. AJR Am J Roentgenol. 2000; 175(4): 1161-1168.
  • Delongchamps N.B. et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU International 107, 1411-1418 (2011).
  • Effert P. J. et al. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose. J. Urol. 155, 994-998 (1996).
  • Emory T.H. et al. Use of CT to reduce understaging in prostatic cancer: comparison with conventional staging techniques//AJR Am J Roentgenol. 1983. Vol. 141, № 2. P. 351-354.
  • Engeler C.E., Wasserman N.F., Zhang G. Preoperative assessment of prostatic carcinoma by computerized tomography. Weaknesses and new perspectives//Urology. 1992. Vol. 40, № 4. P. 346-350.
  • Evangelista L. et al. Comparative studies of radiolabeled choline positron emission tomography, histology of primary tumor and other imaging modalities in prostate cancer: a systematic review and meta-analysis. Clin Transl Imaging 1, 99-109 (2013).
  • Frauscher F, Klauser A, Volgger H, et al. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 2002; 167: 1648-1652.
  • Glazer DI, Davenport MS, Khalatbari S, et al. Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer. Abdom Imaging 2014.
  • Golimbu M. et al. CAT scanning in staging of prostatic cancer//Urology. 1981. Vol. 18, № 3. P. 305-308.
  • Halpern EJ, Frauscher F, Strup SE, et al. Prostate: high-frequency Doppler US imaging for cancer detection. Radiology. 2002; 225(1): 71-77.
  • Halpern EJ, Ramey JR, Strup SE, et al. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer. 2005; 104(11):2373-2383.
  • Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrastenhanced us for detection. Radiology. 2001; 219(1): 219-225.
  • Halpern EJ. Contrast-enhanced ultrasound imaging of prostate cancer. Rev Urol. 2006;(8 suppl 1): S29-S37.
  • Hamoen E.H.J. et al. Use of the Prostate Imaging Reporting and Data System (PI-RADS) for Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: A Diagnostic Meta-analysis//Eur. Urol. 2015. Vol. 67, № 6. P. 1112-1121.
  • Hawighorst H, Knopp MV, Debus J, et al. Pharmacokinetic MRI for assessment of malignant glioma response to stereotactic radiotherapy: initial results.//J Magn Reson Imaging 1998; 8: 783-788.
  • Heijmink S, van Moerkerk H, Kiemeney L, et al. A comparison of thediagnostic perfor mance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol. 2006;16(4): 927-938.
  • Hricak H, White S, Vigneron D, et al. Cancer of the prostate gland: MR imaging with pelvic-phased-array coils versus integrated endorectal-pelvic phased -array coils.//Radiology 1994; 193: 703-709.
  • Hricak H. et al. Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging//Radiology. 1987. Vol. 162, № 2. P. 331-336.
  • Hricak H. MR imaging and MR spectroscopic imaging in the pre-treatment evalution of prostate cancer//Br. J. Radiol. -2005. -Vol. 78, Spec. №2. -P 103-111.
  • Jia J.B. et al. Prostate cancer on computed tomography: A direct comparison with multi-parametric magnetic resonance imaging and tissue pathology//European Journal of Radiology. 2016. Vol. 85, № 1. P. 261-267.
  • Karaman CZ, Unsal A, Akdilli A, et al. The value of contrast enhanced power Doppler ultrasonography in differentiating hypoechoic lesions in the peripheral zone of prostate. Eur J Radiol 2005; 54: 148-155.
  • Kasel-Seibert M. et al. Assessment of PI-RADS v2 for the Detection of Prostate Cancer//Eur J Radiol. 2016. Vol. 85, № 4. P. 726-731.
  • Kim JK, Hong SS, Choi YJ, et al. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.//J Magn Reson Imaging 2005; 22: 639-646.
  • Langer D. L. et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 30, 327-334 (2009).
  • Langer, D. L. et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K(trans), v(e), and corresponding histologic features. Radiology 255, 485-494 (2010).
  • Lin W.-C. et al. Multiparametric Magnetic Resonance Imaging of the Prostate: Diagnostic Performance and Inter-reader Agreement of Two Scoring Systems//Br J Radiol. 2016. P. 20151056.
  • Maricic A, Valencic M, Sotosek S, Oguic R, Ivancic A, Ahel J. Transrectal sonography in prostate cancer detection-our 25 years experience of implementation. Coll Antropol. 2010 Apr;34 Suppl 2: 239-42.
  • Mitterberger M, Aigner F, Pinggera GM, et al. Contrast-enhanced colour Doppler-targeted prostate biopsy: correlation of a subjective blood-flow rating scale with the histopathological outcome of the biopsy. BJU Int 2010; 106:1315-1318.
  • Mitterberger M, Pinggera GM, Horninger W, et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol. 2007; 178(2): 464-468.
  • Morelli G, Pagni R, Mariani C, et al. Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer. J Urol 2011; 185: 2126-2131.
  • Muller B.G. et al. Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging//Radiology. 2015. Vol. 277, № 3. P. 741-750.
  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version2.2013. http://www.nccn.org/professionals/physi-cian_gls/pdf/prostate.pdf. Accessed March 15, 2013.
  • NCCN guidelines Prostate Cancer Early Detection v1-2016.
  • Parker C. et al. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up//Ann Oncol. 2015. Vol. 26, № suppl 5. P. v69-v77.
  • Pelzer A, Bektic J, Berger AP, et al. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol. 2005; 173(6): 1926-1929.
  • Peng Wang, You-min Guo, Min Liu, Yong-qian Qiang, Xiao-juan Guo, Yi-li Zhang, Xiao-Yi Duan, Qiu-Juan Zhang, Weifeng Liang. A Meta-Analysis of the Accuracy of Prostate Cancer Studies Which Use Magnetic Resonance Spectroscopy as a Diagnostic Tool. Korean J Radiol 2008;9: 432-438.
  • Peng Wang, You-min Guo, Min Liu, Yong-qian Qiang, Xiao-juan Guo, Yi-li Zhang, Xiao-Yi Duan, Qiu-Juan Zhang, Weifeng Liang. A Meta-Analysis of the Accuracy of Prostate Cancer Studies Which Use Magnetic Resonance Spectroscopy as a Diagnostic Tool. Korean J Radiol 2008; 9: 432-438.
  • Perrotti M, Kaufman RP Jr, Jennings TA, et al. Endo-rectal coil magnetic resonans imaging in clinically localized prostate cancer: is it accurate?//J Urol 1996; 156: 106-109.
  • Poon, P.Y. et al. Magnetic resonance imaging of the prostate. Radiology 154, 143-149 (1985).
  • Port RE, Knopp MV, Hoffmann U, Milker-Zabel S, Brix G. Multicompartment analysis of gadolinium chelate kinetics: blood-tissue exchange in mammary tumors as monitored by dynamic MR imaging.//J Magn Reson Imaging 1999; 10:233-241.
  • Prando A,Wallace S. Helical CT of prostate cancer: early clinical experience. AJR Am J Roentgenol 2000; 175: 343-6.
  • Prostate cancer: diagnosis and management. NICE, 2014.
  • Quinn SF, Franzini DA, Demlow TA, et al. MRI of prostate cancer with an endorectal surface coil technique: correlation with whole mount specimens.//Radiology 1994;190:323-327.
  • Ratnam S, Kent C: Early increase in choline kinase activity upon induction of the H-ras oncogene in mouse fibroblast cell lines. Arch Biochem Biophys 323: 313-322, 1995.
  • Renard-Penna R. et al. Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy//Radiology. 2015. Vol. 275, № 2. P. 458-468.
  • Roy C, Buy X, Lang H, et al. Contrast enhanced color Doppler endorectal sonography of prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 2003; 170(1): 69-72.
  • Ruprecht O. et al. MRI of the prostate: Interobserver agreement compared with histopathologic outcome after radical prostatectomy//European Journal of Radiology. 2012. Vol. 81, № 3. P. 456-460.
  • Ruprecht O. et al. MRI of the prostate: interobserver agreement compared with histopathologic outcome after radical prostatectomy//Eur J Radiol. 2012. Vol. 81, № 3. P. 456-460.
  • Salomon G, Kellerman J, Thederan I, et al. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol. 2008;54(6): 1354-1362.
  • Scheidler J. et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging-clinicopathologic study//Radiology. 1999. Vol. 213, № 2. P. 473-480.
  • Schieda N, Al-Dandan O, Shabana W, Flood TA, Malone SC. Is primary tumor detectable in prostatic carcinoma at routine contrast-enhanced CT? Clinical Imaging 39 (2015) 623-626.
  • Schnall MD, Lenkinski RE, Pollack HM, Imai Y, Kressel HY. Prostate: MR imaging with an endorectal surface coil.//Radiol-ogy 1989; 172: 570-574.
  • Seitz M, Gratzke C, Schlenker B, et al. Contrast-enhanced transrectal ultrasound (CE-TRUS) with cadence-contrast pulse sequence (CPS) technology for the identification of prostate cancer. Urol Oncol 2011; 29: 295-301.
  • Steyn, J. H. & Smith, F. W. Nuclear Magnetic Resonance (NMR) Imaging of the Prostate. British Journal of Urology 56, 679-681 (1984).
  • Steyn, J. H. & Smith, F. W. Nuclear magnetic resonance imaging of the prostate. Br J Urol 54, 726-728 (1982).
  • Tanimoto A, Nakashina J, Kohno H, et al. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.//J Magn Recon Imaging. 2007; 25: 146-152.
  • Taymoorian K, Thomas A, Slowinski T, et al. Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies. Anticancer Res 2007; 27: 4315-4320.
  • Teng J, Chen M, Gao Y, Yao Y, Chen L, Xu D. Transrectal sonoelastography in the detection of prostate cancers: A Meta-Analysis. BJUI, 2012.
  • Unal D, Sedelaar JP, Aarnink RG, et al. Three-dimensional contrastenhanced power Doppler ultrasonography and conventional examination methods: the value of diagnostic predictors of prostate cancer. BJU Int 2000; 86: 58-64.
  • Watanabe H. et al. Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging. J Magn Reson Imaging 31, 1151-1156 (2010)
  • Xie SW, Li HL, Du J, et al. Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography. BJU Int 2011; 109: 1620-1626.
  • Yanmi Li, MD, Jie Tang, MD, Xiang Fei, MD, Yi Gao, MD. Diagnostic Performance of Contrast Enhanced Ultrasound in Patients with Prostate Cancer: A MetaAnalysis. AUR, 2013.
Еще
Статья
QR-код для установки приложения SciUp Наведите камеру и скачайте бесплатное приложение SciUp